Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Acamprosate in Treating Alcohol Use Disorder in the Post Liver Transplant Populations

NCT06471686 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT06471686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06471686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Acamprosate in Treating Alcohol Use Disorder in the Post Liver Transplant Populations
Lead sponsor
University of Southern California
Phase
Phase 2
Overall status
Completed
Start date
December 1, 2021
Completion date
October 30, 2023
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, liver transplant; complications